About Andrew Firlik
Andrew Firlik is a director at Swing Therapeutics.
Andrew Firlik first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew Firlik in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andrew Firlik works with at each company, as listed on that company's latest Form D.
Swing Therapeutics, Inc. · Form D, Sep 15, 2025